Listed Products of GLP-1 Receptor Agonists (GLP-1RA) At present, 9 GLP-1 receptor agonist hypoglycemic drugs have been approved for marketing in the world, namely: exenatide, liraglutide, Exenatide extended-release (exenatide ER), albiglutide, dulaglutide , lixisenatide, benaglutide, semaglutide, polyethylene glycol loxenatide injection and oral semaglutide
For patients with type 2 diabetes, there is an increased risk of hypoglycaemia when Wegovy is used with insulin or sulfonylureas, and doses of these medications may need adjustment
Once the IV is in place, the infusion is painless
Side Effects People Report The most common complaints are mild: pain, redness, or bruising where the shot is given
doi:10.3389/fphar.2022.925377 Bezin J, Gouverneur A, Pnichon M, Mathieu C, Garrel R, Hillaire-Buys D, et al
Review your plans drug formulary at anthem.com or contact Anthem member services to confirm whether your plan covers weight loss medications